|
Welcome to JLJ's e-newsletter - China
Focus. With our latest articles, we hope to share with
you insights on the latest China regulatory updates, trends, and other
news. Each month, we bring this
e-newsletter to you as part of JLJ's value-added service.
|
|
|
|
|
China's 12th
Five-Year Plan: Key Areas in Healthcare Industry
This article is the
fourth in a series of articles covering several industry specific
Five-year plans.
China
has 1.4 billion people of which 160 million are above the age of 60,
which is the key demographic utilizing medical services; by 2025, the
number of people over the age of 60 is expected to reach 300 million.
Additionally, with over 80% of medical services concentrated in urban
centers, there are over 100 million people in rural areas that do not
have basic access to medical care. These two critical statistics have
helped push the central government to focus on healthcare system reform.
Therefore, in 2009 the
central government announced an RMB 850 billion three-year healthcare
reform package that included:
- Improve healthcare
facilities (e.g. hospitals and clinics, especially in rural areas)
- Universalize access to
basic healthcare
- Revamp the pharmaceutical
supply system
The 12th five-year plan
further expands the 2009 healthcare package, putting further emphasis
on reform with specific policies and funding, for example:
-
Biotechnology
- now considered a Strategic Emerging Industry (SEI) by the central
government, there is an effort to build this into a pillar industry
with plans to inject RMB 12 billion into research & development
-
Pharmaceutical
consolidation - with over 13,000 pharmaceutical wholesalers,
the central government has plans to consolidate the industry and create
3 large nationwide pharmaceutical groups and approximately 20 regional
pharmaceutical companies
-
Increase medical
insurance coverage - Currently, 95% of the population has
basic insurance coverage; the target is to reach 100% by 2020 and raise
reimbursement rates for patients
Opportunities may exist
for foreign companies in China's healthcare sector, especially in
pharmaceuticals, more than ever as the Ministry of Commerce (MOFCOM)
seeks to increase foreign investments in pharmaceuticals, and that
China is expected to be the world's second largest medical devices
market, estimated to be valued at RMB 360 million by 2020.
However, for companies
approaching the China market, it is recommended that the company fully
understand the market dynamics and all risks and benefits associated
with it before making any significant investment decisions.
For inquiries about this
article, or other work of our consulting division, please email Mark
Ray at mark.ray@jljgroup.com
.
Back to Top
Shanghai to Lead Pilot Tax Reform
Last
month, China's State Council had announced a pilot tax reform program
("the pilot"), which will be implemented in specific regions and
industries. The Pilot, to be first launched on January 1st, 2011 in
Shanghai, is designed to resolve issues with double taxation and expand
the development of the value-added tax (VAT) system with VAT gradually
replacing the function of Business Tax.
On November 16th, 2011
Circular 110 and 111 were jointly issued by China's Ministry of Finance
(MOF) and the State Administration of Taxations (SAT) to elaborate on
the pilot's implementation details. While these circulars do not cover
all related matters, they do serve as guidelines to clear up some
issues.
Circular 110 introduces
the VAT reform pilot general plan. The pilot will be first implemented
in Shanghai for certain business types and with different rates, these
include:
- Leasing of moveable and
tangible goods: 17%
- Transportation and
construction services: 11%
- Other modern services
sectors: 6%
Businesses
in Shanghai who's activities due not fall in those categories will be
unaffected. Only after conditions are mature will the reform be
extended nationwide and cover additional sectors.
Circular
111 specifies the rules for the Shanghai VAT reform pilot
implementation. The circular goes into more detail on the scope of
industries and application of VAT, guidance on deductions for input
VAT, and how current business tax incentives will be preserved. In
addition, the circular stipulates that the rules for input VAT credit,
simplified taxation method, the point of taxation, and classification
of tax payers will remain unchanged.
While
the pilot program is generally well received and should alleviate
issues with the current system, there are some caveats. Business who
are able to recover VAT under the current system will see an immediate
benefit, but those with limited input VAT may benefit less if their new
VAT rates are higher than current business tax rates. To prepare for
the pilot reforms, companies should engage a tax professional to best
plan their strategy.
To
learn more about the upcoming pilot reforms, contact andrea.cristancho@jljgroup.com.
Back to Top
Case Study: Reassigning an Unqualified Employee
In most cases, any
adjustment to a labor contact and work conditions requires mutual
agreement between the employer and the employee, only then may the
contract may be altered in writing. However, there are a few exceptions
to be aware of, such as in cases of reassigning an unqualified employee
to a new position. The following is an actual case in which an employee
was deemed unqualified, and as a consequence the employer wished to
reassign them.
Mr. Zhang was recently
hired as a packaging machine operator and signed a three-year contract
with his employer. Following a 6 month probation period, he began to
work independently. However, over the following month he failed to
fulfill expectations and made several crucial mistakes.
The company decided that
rather than try to retrain and improve Mr. Zhang's performance in his
position as machine operator, they would instead transfer him to
another position with duties that are relatively easy compared to his
original task. The company then sent Mr. Zhang a written "Position
Adjustment Notification", informing him to report to the new
position. Mr. Zhang felt the employer did not have the right to
reassign him. He did not accept the notice and chose not to report to
the new position or go to work at all.
On
the second day of absence, the company sent an official written notice
demanding Mr. Zhang’s attendance at work. However, after no reply and 3
days of absence, he was found to be in violation of company policy and
the only remaining option was to terminate the employment relationship.
In this case the employer
had the legal right to reassign their employee based on performance,
and ultimately dismiss the employee for failure to comply. According to
article 40 of the Labor Contract Law of China, "on the
occasion that the employee is not qualified for the current position,
the employer has the right to make reasonable adjustment."
This regulation applies
well to the case above. As opposed to other contract adjustments
subject to mutual agreement, reassigning an employee based on a lack of
ability in performing current duties is within the legal rights of an
employer, and requires no employee agreement. Nevertheless, employers
should note that reassignment not based on poor performance and without mutual agreement is illegal.
For more information on
Labor Contract readjustments in China, email vicky.chen@jljgroup.com.
Back to Top
China's
"Silicon Valley" to Receive Investment Boost
Zhongguancun
National Independent Innovation Demonstration Zone, China's "Silicon
Valley" will be part of the central government's scheme to develop
modern services industries. Over the next three to five years, Beijing
plans to invest 1.5 billion RMB into the zone.
The Finance Bureau of
Beijing recently issued the "Management of the Pilot Supportive Fund
for Modern Service Development in Zhongguancun National Independent
Innovation Demonstration Zone". The fund will be available for use in
several tech-based service sectors including:
- Emerging information
technology based service industries
- E-commerce and modern
logistics industries
- Technology service
industries
- Energy-saving and
environmental protection industries
- Additional sectors listed
in the government's annual guidelines
|
Any company registered in
the Zhongguancun zone which is involved in the above sectors can apply
for the use of the fund. The following are the primary methods of fund
use:
-
Subsidies to support
public services, brand promotion, market expansion, and professional
training. Such subsidies should not exceed 10 million RMB per project.
-
Private equity funds used
to support emerging industries, innovation projects and financing
projects. Private equity funds should not exceed 50 million RMB per
project.
-
Subsidized loans for the
support of emerging industries and innovation projects. Such loans
should not exceed 10 million RMB per project.
-
Rewards for support
fast-growing and green projects. These should not exceed 20 million RMB
per project.
In the past two decades
the Zhongguancun zone has attracted nearly 20,000 new and high-tech
companies and is home to over a thirty top colleges and universities,
including Beijing and Qinghua University, as well as over 200 national
and provincial research institutes. Tenants of the zone include top
international companies with nearly 200 branches and R&D centers of
companies in the fortune 500. For 2010, the total revenue for companies
in the zone reached 1.59 trillion RMB.
For more information
about Zhongguancun National Independent Innovation Demonstration Zone,
contact Tim Lamb tim.lamb@jljgroup.com.
Back to Top
|